Published 2 days ago • loading... • Updated 2 days ago

Latham, White & Case Advise on $11B Funds' Offer for Italy's Recordati Pharmaceutical Company

A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.

9 Articles

Pharmaphorum

Center

GBL joins CVC in €10.7bn takeover bid for Recordati

A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.

2 days ago

Read Full Article

Handelsblatt

Lean Right

Pharma: Investors Offer Billions for Pharmaceutical Company Recordati

The financial investors CVC Capital Partners and Groupe Bruxelles Lambert present a billion-dollar offer for the pharmaceutical group. At the same time, they plan to withdraw it from the stock exchange.

2 days ago·Düsseldorf, Germany

Read Full Article

La Libre

Center

GBL and CVC Want to Get Their Hands on an Italian Giant of the Drug

The Belgian group GBL is on the offensive with CVC to offer Recordati, an Italian heavyweight of the medicine valued at more than 10 billion euros. ...

2 days ago·Brussels, Belgium

Read Full Article

Law.com

Center

Latham, White & Case Advise on $11B Funds' offer for Italy's Recordati Pharmaceutical Company

2 days ago

Read Full Article

endpoints.news

Tender offer for Recordati; Sobi's gout drug passes Phase 3 test

Plus, news about Immunovant and Retro Biosciences. 💸 CVC and GBL launch tender offer for Recordati: CVC Capital Partners and Groupe Bruxelles Lambert (GBL), a Belgian investment holding company, launched their cash voluntary tender

2 days ago

Read Full Article